Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Mosaic ImmunoEngineering Inc. (CPMV) had Consolidated Net Income/Loss of $-0.18M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-0.18M |
|
-- |
|
-- |
|
$0.15M |
|
$-0.15M |
|
$-0.02M |
|
$-0.18M |
|
$-0.18M |
|
$-0.18M |
|
$-0.18M |
|
|
Consolidated Net Income/Loss |
$-0.18M |
$-0.18M |
|
$-0.15M |
|
$-0.15M |
|
7.24M |
|
7.24M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$0.01M |
|
-- |
|
-- |
|
$0.01M |
|
$6.18M |
|
$1.48M |
|
$1.48M |
|
$7.66M |
|
$-7.65M |
|
$-7.65M |
|
$-7.65M |
|
7.24M |
|
| Cash Flow Statement Financials | |
$-0.00M |
|
-- |
|
-- |
|
$0.00M |
|
$0.00M |
|
$-0.00M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.00 |
|
-- |
|
-- |
|
-0.24 |
|
-0.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
2.29% |
|
2.29% |
|
-1784.20% |
|
2.84% |
|
$-1.06 |
|
$-0.00 |
|
$-0.00 |
|